Insmed | INSM - Aktywa

Cena Akcji
134.66
Dzienna Zmiana
-1.67 -1.23%
Miesięcznie
-17.10%
Rocznie
86.25%
Q2 Prognozy TE
132.28




Aktywa Zmiana Data
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Cytokinetics USD 916.97M 60.37M 2025-12
DBV Technologies USD 212.94M 124.06M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Insmed USD 1.79B 137.6M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12